Inventor · disambiguated record
Ralph Mazitschek
Also filed as: MAZITSCHEK RALPH
63 granted patents·32 pending applications·471 citations·filing 2002–2024
99Inventor score
Files withACETYLON PHARMACEUTICALS INC17MASSACHUSETTS GEN HOSPITAL14REGENACY PHARMACEUTICALS LLC11HARVARD COLLEGE10CHILDRENS MEDICAL CT CORP8
Top patents by PatentIndex Score
95 records- 0198US9145412B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2013·Granted Sep 29, 2015·30 cites·32 claims
- 0297US9421212B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Aug 23, 2016·12 cites·9 claims
- 0396US9464073B2Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·10 cites·12 claims
- 0496US9139583B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·20 cites·11 claims
- 0595US9096549B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Aug 4, 2015·26 cites·18 claims
- 0695US8614223B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Dec 24, 2013·34 cites·16 claims
- 0795US8148526B1Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Apr 3, 2012·38 cites·4 claims
- 0894US9790180B2Piperidine derivatives as HDAC1/2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·6 cites·7 claims
- 0994US8609678B2Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2012·Granted Dec 17, 2013·30 cites·9 claims
- 1094US8394810B2Reverse amide compounds as protein deacetylase inhibitors and methods of use thereofVAN DUZER JOHN H·Filed 2011·Granted Mar 12, 2013·32 cites·4 claims
- 1193US10239837B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2017·Granted Mar 26, 2019·4 cites·5 claims
- 1293US10005793B2Bodipy dyes for biological imagingMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Jun 26, 2018·30 cites·8 claims
- 1393US9988343B2Inhibitors of histone deacetylaseDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 5, 2018·7 cites·22 claims
- 1493US9765066B2Selective HDAC1 and HDAC2 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Sep 19, 2017·6 cites·14 claims
- 1592US8383855B2Histone deacetylase inhibitorsHARVARD COLLEGE·Filed 2007·Granted Feb 26, 2013·14 cites·35 claims
- 1690US9562013B2Selective HDAC3 inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Feb 7, 2017·7 cites·11 claims
- 1790US9278963B2Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·17 cites·24 claims
- 1890US8999289B2Treatment of protein degradation disordersANDERSON KENNETH C·Filed 2006·Granted Apr 7, 2015·16 cites·32 claims
- 1990US8754237B2Bifunctional histone deacetylase inhibitorsBRADNER JAMES ELLIOT·Filed 2012·Granted Jun 17, 2014·18 cites·13 claims
- 2088US9409890B2Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2013·Granted Aug 9, 2016·9 cites·8 claims
- 2187US10358421B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2017·Granted Jul 23, 2019·2 cites·17 claims
- 2287US9968575B2Compounds for the treatment of obesity and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2013·Granted May 15, 2018·6 cites·5 claims
- 2387US9884850B2Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·2 cites·9 claims
- 2487US9572854B2Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2015·Granted Feb 21, 2017·6 cites·20 claims
- 2586US9925161B2Compounds for the treatment of obesity and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Mar 27, 2018·3 cites·23 claims
- 2686US9284297B2Halofuginone analogs for inhibition of tRNA synthetases and uses thereofKELLER TRACY·Filed 2009·Granted Mar 15, 2016·27 cites·29 claims
- 2786US8716344B2Class- and isoform-specific HDAC inhibitors and uses thereofMAZITSCHEK RALPH·Filed 2010·Granted May 6, 2014·8 cites·21 claims
- 2886US8304451B2Histone deacetylase and tubulin deacetylase inhibitorsMAZITSCHEK RALPH·Filed 2007·Granted Nov 6, 2012·11 cites·31 claims
- 2985US2025161252A1Compounds for the treatment of obesity and methods of use thereofTHE CHILDREN’S MEDICAL CENTER CORP·Filed 2024·Application pending·0 cites
- 3084US8222423B2Bifunctional histone deacetylase inhibitorsBRADNER JAMES ELLIOT·Filed 2007·Granted Jul 17, 2012·17 cites·13 claims
- 3184US2023348389A1Piperidine derivatives as hdac1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 3283US10828367B2Photoswitchable HDAC inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Nov 10, 2020·1 cites·16 claims
- 3383US10172905B1Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2017·Granted Jan 8, 2019·3 cites·20 claims
- 3482US9199923B2Histone deacetylase inhibitorsHARVARD COLLEGE·Filed 2014·Granted Dec 1, 2015·3 cites·22 claims
- 3581US2025213561A1Selective hypothalamus permeable hdac6 inhibitors for treatment of leptin-resistant obesityTHE CHILDREN’S MEDICAL CENTER CORP·Filed 2024·Application pending·0 cites
- 3679US10774056B2Substituted piperazines as selective HDAC1,2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2019·Granted Sep 15, 2020·1 cites·4 claims
- 3778US10662218B2Analogs of celastrolERX PHARMACEUTICALS INC·Filed 2016·Granted May 26, 2020·4 cites·48 claims
- 3878US2024252496A1Selective hypothalamus permeable hdac6 inhibitors fortreatment of leptin-resistant obesityTHE CHILDREN’S MEDICAL CENTER CORP·Filed 2024·Application pending·0 cites
- 3977US9540317B2Class- and isoform-specific HDAC inhibitors and uses thereofHARVARD COLLEGE·Filed 2014·Granted Jan 10, 2017·2 cites·39 claims
- 4077US9505735B2Compounds for treating infectious diseasesWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Nov 29, 2016·3 cites·38 claims
- 4177US2024139187A1Selective hypothalamus permeable hdac6 inhibitors for treatment of leptin-resistant obesityCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 4276US12064408B2Compounds for the treatment of obesity and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Aug 20, 2024·0 cites·19 claims
- 4375US11702389B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2021·Granted Jul 18, 2023·0 cites·19 claims
- 4475US10370324B2Phenyl and pyridinyl hydroxamic acidsACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·10 claims
- 4575US10125131B2Selective HDAC3 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2016·Granted Nov 13, 2018·1 cites·23 claims
- 4675US9724321B2Histone deacetylase inhibitorsHARVARD COLLEGE·Filed 2015·Granted Aug 8, 2017·1 cites·19 claims
- 4774US9981038B2Photoswitchable HDAC inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted May 29, 2018·2 cites·13 claims
- 4873US10968180B2Piperidine derivatives as HDAC1/2 inhibitorsREGENACY PHARMACEUTICALS LLC·Filed 2019·Granted Apr 6, 2021·0 cites·7 claims
- 4972US11596691B2Photoswitchable HDAC inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Mar 7, 2023·0 cites·3 claims
- 5072US10927072B2Phenyl and pyridinyl hydroxamic acidsACETYLON PHARMACEUTICALS INC·Filed 2019·Granted Feb 23, 2021·0 cites·7 claims
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ralph Mazitschek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →